Beardsley, Robert A.,Riley, Dennis P.,Keene, Jeffery L.,Spitz Jr., Douglas R.,Fath, Melissa A.
申请号:
AU2017260425
公开号:
AU2017260425A1
申请日:
2017.05.03
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
The present disclosure generally relates to combination therapies for cancer treatment, including administration of a pentaaza macrocyclic ring complex corresponding to formula (1), and active agent that is at least one of a thioredoxin reductase inhibitor and a glutathione- depleting agent.